Patent · US Active

Antibody compositions

US11351257B2 · kind B2 · utility

1Cited by

4References

22Claims

0Family size

Assignee

PHILOGEN S.P.A. · IT

Inventors

Giovanni Neri · Siena, IT
Camilla Bacci · Colle Ciupi, IT

Key dates

Filing date	Jul 14, 2017
Grant date	Jun 7, 2022
Priority date	—
Expiry date	Aug 20, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to stable formulations that can be prepared to high concentration of active agent using low amounts of detergents and to methods for producing such formulations. In particular, this invention relates to formulations containing the L19-TNFα immunocytokine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.